Chronic skin inflammation -- the persistent background inflammatory state that maintains conditions like eczema, rosacea, psoriasis, and hormonal acne -- is not a simple process. It is a network of cytokine signals, immune cell activations, and feedback loops that reinforce each other and resist resolution. CBD addresses this network through specific molecular mechanisms that target the cytokine pathways at the center of chronic skin inflammation.
The Central Cytokines in Chronic Skin Inflammation
TNF-alpha: The master inflammatory cytokine that activates downstream inflammatory cascades, recruits immune cells to inflamed tissue, and maintains the inflammatory microenvironment. Elevated in eczema, psoriasis, rosacea, and acne.
IL-6: A pleiotropic cytokine that amplifies inflammation and activates acute phase responses. Elevated in most chronic inflammatory skin conditions.
IL-1beta: An early inflammatory signal that initiates and sustains the inflammatory cascade. Particularly relevant in acne (where it activates the NLRP3 inflammasome) and eczema.
IL-17: A cytokine produced by Th17 immune cells that is central to the inflammatory mechanism of psoriasis and is increasingly recognized in other inflammatory skin conditions.
How CBD Inhibits These Cytokines
CBD's primary cytokine-inhibiting mechanism operates through CB2 receptor activation on skin immune cells. When CBD binds to CB2 receptors on macrophages, mast cells, and T cells in the skin, it activates intracellular signaling pathways that reduce the transcription of pro-inflammatory cytokine genes -- particularly TNF-alpha, IL-6, IL-1beta, and IL-17.
This transcriptional suppression means that CBD does not just block released cytokines -- it reduces their production at the source. The effect is cumulative with consistent application: each dose of CBD maintains the CB2-mediated suppression of cytokine gene expression, gradually reducing the inflammatory tone of the skin over weeks of use.
Why Consistent Application Matters
The CB2-mediated cytokine reduction that CBD produces requires consistent receptor occupancy to maintain. CBD applied once does not produce lasting receptor activation -- the cannabinoid is metabolized and the receptors return to baseline. Twice-daily application of Restore maintains consistent CB2 activation, providing continuous cytokine suppression that allows the chronic inflammatory state to progressively resolve rather than being temporarily interrupted.
Golden Tallow Restore is coming.
CBD in a wagyu tallow base. No seed oils. No synthetic preservatives. The most bioavailable topical CBD delivery system available -- built on the same ancestral skincare foundation as the Opulent Facial Elixir. Early access is open now.
Join the Early Access List Learn More About RestoreBe among the first to experience Golden Tallow Restore. Join the early access list at early.goldentallow.com and explore the full Golden Tallow lineup at goldentallow.com. 🤍